when is retatrutide coming out Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation RETATRUTIDE (RETA)

By comparison, this revised peak estimate is more than double the $79 billion in total sales recorded in 2025

This projects approval around Q3 2027 under an optimistic priority-review scenario, or Q1Q2 2028 under standard review

In one 2002 paper published in the Journal of Gerontology: Medical Sciences, researchers conducted a meta-analysis examining the relationship between low B12 levels and continence in older people

Our pharmacists are available to answer any questions you may have and to help ensure you can make decisions that will positively impact your weight loss journey

Epigenetic mechanisms activated by GHK-Cu increase skin collagen density in clinical trial (IRB-approved 21-woman NEEL gel trial